Public signalCompany raiseAuto-indexed · Unverified
Synedgen, Inc. raised $1.8M
Synedgen, Inc.· CLAREMONT, US· Pharmaceuticals· Filed Oct 1, 2024
Synedgen, Inc. reported raising capital. Based in CLAREMONT, CALIFORNIA, US. First sale reported 2024-09-11. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$1.8M
Confidence90%
Raised
$1.8M
Investors
4
Jurisdiction
DELAWARE
On the record
- Location
- CLAREMONT, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $1.8M
- Target amount
- $2.0M
- Filing date
- Oct 1, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Pharmaceuticals
- Number of investors
- 4
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $2.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Andrew W. Miller
Director
Claremont, US
Daniel Bradbury
Director
Claremont, US
Hal Oien
Director
Claremont, US
Kaveri Parker
Executive Officer
La Jolla, US
Kenton Gregory
Director
Claremont, US
Paul C. Grint
Director
Claremont, US
Shenda Baker
Executive Officer
Claremont, US
William P. Wiesmann
Executive Officer
Claremont, US
Sources & provenance
“Operating company sold 1,750,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Oct 1, 2024. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticals$1M – $10MCompany Raise
Are you associated with Synedgen, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record